Skip to main content
Have a personal or library account? Click to login
Brain-kidney crosstalk in subarachnoid hemorrhage patients Cover

Figures & Tables

Fig. 1.

Flowchart of study population

Legend: SAH – Subarachnoid Hemorrhage; TBI– Traumatic Brain Injury.

Table 1.

Demographic and Baseline Patients' Characteristics (n=15)

Gender, male n (%)5 (33)
Age, median (P25-P75)58 (37–62)
LOS in ICU, median (P25-P75)23 (15–29)
LOS in hospital, median (P25-P75)40 (29–64)
SAPS II, median (P25-P75)47 (28–56)
SAPS II mortality %, median (P25-P75)39 (9–60)
GCS at first aid, median (P25-P75)13 (8–15)
GCS at hospital, median (P25-P75)12 (3–14)
SAH H&H, n (%)
I0 (0)
II5 (33)
III3 (20)
IV2 (13)
V5 (33)
SAH Fisher, n (%)
10 (0)
20 (0)
30 (0)
415 (100)
SAH vasospasm, n (%)8 (53)
Mortality at ICU discharge, n (%)2 (13)
Creatinine Clearance at admission (ml/min/1.73 m2), median (P25-P75)
MCC139 (120–243)
CG104 (75–155)
MDRD127 (89–173)
CKD-EPI112 (83–131)
Vasopressors on day 1 (Noradrenaline) Dose (mcg/kg/min), median (P25-P75)0.19 (0.07–0.32)
Number of patients on diuretics on day 1, n (%)2 (15)

[i] GCS – Glasgow Coma Scale; LOS – length of stay; MCC–Measured Creatinine Clearance; SAH H&H – Hunt and Hess classification for Spontaneous Subarachnoid hemorrhage (SAH); SAH Fisher – Fisher classification for SAH; SAPS II – Simplified Acute Physiology Score; MDRD – abbreviated Modification of Diet in Renal Disease Study Equation; CKD-EPI – Chronic Kidney Disease Epidemiology Collaboration

Fig. 2.

Global Median MCC evolution during the first 14 days of ICU stay

Legend: MCC – Measured Creatinine Clearance (mL/min/1.73 m2); Time – length of stay in ICU (days).

Fig. 3.

Correlation between MCC and PRx

Legend: MCC – Measured Creatinine Clearance (mL/min/1.73 m2); PRx – Pressure reactivity index

Table 2.

Factors associated with creatinine clearance

Fixed-effect factor
CoefficientCI 95%p-value
Gender – Female15.18−43.79;74.070.615
Age−1.33−2.81;0.150.080
Number of days (Time)0.51−1.61;2.640.635
CPP0.64−0.30;1.590.185
PRx−18.39−61.48;23.640.393
CPP-optCPPPRx−0.71−1.74;0.300.169
Noradrenaline−37.15−90.77;16.950.175
Fluid balance−0.002−0.009;0.0000.632

[i] MCC – Measured Creatinine Clearance; CI 95% – 95% Confidence intervals; CPP – Cerebral Perfusion Pressure; PRx – Pressure Reactivity index; optCPPPRx – optimal CPP evaluated with PRx; CPP-optCPPPRx – CPP given to the patient minus optimal CPP evaluated with PRx.

DOI: https://doi.org/10.62838/jccm-2026-0037 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 342 - 350
Submitted on: Jul 23, 2025
Accepted on: Jun 18, 2026
Published on: Jul 27, 2026
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Elisabete Monteiro, Sofia Rocha e Silva, Silvina Barbosa, Isaac Barroso, Cláudia Camila Dias, Marek Czosnyka, José Artur Paiva, Celeste Dias, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.